Mesoestetic Launch Mesopeel MD

Mesoestetic, a global leader in medical cosmetics and aesthetic medicine, has announced the launch of Mesopeel MD, the brand’s new line of combination peels designed exclusively for doctors.

According to the company, the new range will feature 12 innovative combination peels, each designed to address key skin concerns such as ageing, pigmentation, oily and acne-prone skin, and sensitivity.

Eight of the 12 peels will incorporate Mesopeel’s MD formula, which includes concentration-weighted chemical exfoliants such as arginine, shikimic acid, and caffeic acid. Arginine stimulates the synthesis of structural proteins, promoting cell regeneration and tissue repair; shikimic acid inhibits cellular senescence through epigenetic mechanisms and balances the production of sebum; and caffeic acid provides antioxidant, anti-inflammatory, and regenerative action.

“We are delighted to announce this new generation of combination peels to treat the main skin conditions. We have seen some excellent immediate and progressive results backed by clinical evidence.” said Adam Birtwistle, Managing Director of Mesoestetic.